Global View of COVID-19: A Pan-African Perspective - POCTRN

Center news

null Global View of COVID-19: A Pan-African Perspective

Global View of COVID-19: A Pan-African Perspective

Our panelists are leaders in their country's response to addressing the pandemic in the face of limited resources.

The worldwide Covid-19 pandemic has affected our partners in sub-Saharan Africa; however, the impact has not been as catastrophic as initially anticipated. The reasons for this are unclear but could be due to its relatively young population, inherent immunity, rapid implementation of mitigation efforts, a coordinated public health response developed in part because of the prior Ebola epidemic. Our panelists are leaders in their country's response to addressing the pandemic in the face of limited resources.

Rob Murphy, MD 
Professor of Infectious Diseases and Biomedical Engineering, co-PI of the Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)

Sade Ogunsola, MBChB, PhD 
Professor of Microbiology, former Vice Chancellor, University of Lagos-Nigeria, Steering Committee Member, African Center for Disease Control

Grant Theron, PhD
Professor of Biomedical Engineering, Stellenbosch University, South Africa

April 6, 2:00PM ET

Watch the recording >

Download the PDF >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.


In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19